IMCD NV's revenue for the
six
months ended in Dec. 2025 was €2,305 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €4,779 Mil.
IMCD NV's Revenue per Share for the
six
months ended in Dec. 2025 was €39.05.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €80.81.
Warning Sign:
IMCD NV revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of IMCD NV was -2.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 11.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, IMCD NV's highest 3-Year average Revenue per Share Growth Rate was 16.50% per year. The lowest was -19.10% per year. And the median was 10.50% per year.
IMCD NV (CHIX:IMCDa) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
IMCD NV Revenue Related Terms
IMCD NV Revenue Historical Data
* Premium members only.
The historical data trend for IMCD NV's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, IMCD NV's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMCD NV Revenue vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, IMCD NV's Revenue distribution charts can be found below:
* The bar in red indicates where IMCD NV's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4,779 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMCD NV (CHIX:IMCDA) has a Revenue of €4,779 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on IMCD NV and its competitors.
Is IMCD NV's Revenue too high?
IMCD NV's current Revenue is €4,779 Mil. Overall, IMCD NV has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's Revenue compare to LIN and SHW?
IMCD NV's Revenue of €4,779 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Chemicals company?
A good Revenue depends on the Chemicals industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on IMCD NV and its competitors. IMCD NV's current Revenue is €4,779 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (CHIX:IMCDA) is currently considered Significantly Undervalued. The stock's GF Value™ is €141.13, compared to a current price of €79.78 — trading 43.5% below its estimated fair value. The current Revenue is €4,779 Mil. IMCD NV's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For IMCD NV (CHIX:IMCDA), the current Revenue is €4,779 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IMCD NV (CHIX:IMCDA) Overvalued in 2026?
Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued.
The current stock price of €79.78 is trading 43.5% below its estimated GF Value™ of €141.13.
GuruFocus considers IMCD NV to be Significantly Undervalued.
Key valuation signals for CHIX:IMCDA:
Revenue: €4,779 Mil
GF Value™: €141.13 vs. price of €79.78 (43.5% below fair value)
No single metric tells the full story. See the CHIX:IMCDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
83GF Score
Get the complete analysis for CHIX:IMCDA
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:IMCDA has been successfully added to your 
